Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyuki Hanada

Showing results (51-60 of 102) with videos related to

Pageof 11
Sort By:
Circulation Reports|April 12, 2021
Comparison of Door-to-Balloon Time and 30-Day Mortality According to Symptom Presentation in Patients With Acute Myocardial InfarctionTakuya Nakahashi, Kenji Sakata, Jun Masuda, et al.
European Journal of Pharmacology|August 16, 2008
Decreased plasma and cardiac matrix metalloproteinase activities in patients with coronary artery disease and treated with pravastatinTakayuki Fujiwara, Shin Saito, Tomohiro Osanai, et al.
Journal of Atherosclerosis and Thrombosis|June 17, 2026
A Case of Familial Chylomicronemia Syndrome Caused by a Novel Homozygous GPIHBP1 Mutation Successfully Treated with the Selective PPARα Modulator PemafibrateTomoko Otsuki, Yumi Chung, Yusuke Kawachi, et al.
International Journal of Cardiology|October 26, 2005
Circulating level of gelatinase activity predicts ventricular remodeling in patients with acute myocardial infarctionToshiro Matsunaga, Naoki Abe, Kunihiko Kameda, et al.
Journal of Cardiovascular Pharmacology|April 9, 2014
Imidapril and enalapril similarly inhibit plasma matrix metalloproteinase activities and attenuate left ventricular remodeling in patients with acute myocardial infarctionTakashi Yokota, Hirofumi Tomita, Yasuhiro Mori, et al.
International Heart Journal|November 30, 2025
The Association Between Body Mass Index and In-hospital Mortality in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary InterventionTakuya Nakahashi, Kenji Sakata, Jun Masuda, et al.
Heart and Vessels|October 6, 2010
Effects of telmisartan on markers of ventricular remodeling in patients with acute myocardial infarction: comparison with enalaprilTakashi Yokota, Tomohiro Osanai, Kenji Hanada, et al.
Heart and Vessels|May 30, 2007
Efficacy and safety of low-dose pioglitazone after primary coronary angioplasty with the use of bare metal stent in patients with acute myocardial infarction and with type 2 diabetes mellitus or impaired glucose toleranceJin Yokoyama, Naoyuki Sutoh, Takumi Higuma, et al.
Journal of Cardiology|May 19, 2022
Impact of hyperuricemia on coronary blood flow and in-hospital mortality in patients with acute myocardial infarction undergoing percutaneous coronary interventionTakuya Nakahashi, Kenji Sakata, Jun Masuda, et al.
Medicine|May 22, 2015
Effects of phenotypic and genotypic factors on the lipid responses to niacin in Chinese patients with dyslipidemiaMiao Hu, Ya-Ling Yang, Chi-Fai Ng, et al.
Pageof 11

Showing results (51-60 of 102) with videos related to

Sort By:
Pageof 11
Circulation Reports|April 12, 2021
Comparison of Door-to-Balloon Time and 30-Day Mortality According to Symptom Presentation in Patients With Acute Myocardial InfarctionTakuya Nakahashi, Kenji Sakata, Jun Masuda, et al.
European Journal of Pharmacology|August 16, 2008
Decreased plasma and cardiac matrix metalloproteinase activities in patients with coronary artery disease and treated with pravastatinTakayuki Fujiwara, Shin Saito, Tomohiro Osanai, et al.
Journal of Atherosclerosis and Thrombosis|June 17, 2026
A Case of Familial Chylomicronemia Syndrome Caused by a Novel Homozygous GPIHBP1 Mutation Successfully Treated with the Selective PPARα Modulator PemafibrateTomoko Otsuki, Yumi Chung, Yusuke Kawachi, et al.
International Journal of Cardiology|October 26, 2005
Circulating level of gelatinase activity predicts ventricular remodeling in patients with acute myocardial infarctionToshiro Matsunaga, Naoki Abe, Kunihiko Kameda, et al.
Journal of Cardiovascular Pharmacology|April 9, 2014
Imidapril and enalapril similarly inhibit plasma matrix metalloproteinase activities and attenuate left ventricular remodeling in patients with acute myocardial infarctionTakashi Yokota, Hirofumi Tomita, Yasuhiro Mori, et al.
International Heart Journal|November 30, 2025
The Association Between Body Mass Index and In-hospital Mortality in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary InterventionTakuya Nakahashi, Kenji Sakata, Jun Masuda, et al.
Heart and Vessels|October 6, 2010
Effects of telmisartan on markers of ventricular remodeling in patients with acute myocardial infarction: comparison with enalaprilTakashi Yokota, Tomohiro Osanai, Kenji Hanada, et al.
Heart and Vessels|May 30, 2007
Efficacy and safety of low-dose pioglitazone after primary coronary angioplasty with the use of bare metal stent in patients with acute myocardial infarction and with type 2 diabetes mellitus or impaired glucose toleranceJin Yokoyama, Naoyuki Sutoh, Takumi Higuma, et al.
Journal of Cardiology|May 19, 2022
Impact of hyperuricemia on coronary blood flow and in-hospital mortality in patients with acute myocardial infarction undergoing percutaneous coronary interventionTakuya Nakahashi, Kenji Sakata, Jun Masuda, et al.
Medicine|May 22, 2015
Effects of phenotypic and genotypic factors on the lipid responses to niacin in Chinese patients with dyslipidemiaMiao Hu, Ya-Ling Yang, Chi-Fai Ng, et al.
Pageof 11